Bibliometric Analysis of the100 Highly-cited Articles about COVID-19

Document Type : LETTER TO THE EDITOR

Authors

Department of Orthopedics, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran

Abstract

We have to indicate that the number of 100 was arbitrary. Collecting a large number of citations dose not necessary indicates that the study is the best and has a high level of evidence. This study by no means negate high quality important articles that have been published recently and had not enough time to increase their citations yet. Findings on COVID-19 Characteristics are rapidly changing and subject to selection bias. The current study was a cross-sectional study on August 6, 2020; therefore, our findings will be changed overtime.

Keywords

References

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.
Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China. The lancet. 2020 Feb
15; 395(10223):497-506.
2. Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI,
Russell TW, et al. Feasibility of controlling COVID-19
outbreaks by isolation of cases and contacts. The
Lancet Global Health. 2020.
3. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir
in adults with severe COVID-19: a randomised, doubleblind,
placebo-controlled, multicentre trial. The Lancet.
2020.
The Archives of Bone and Joint Surgery
Volume 8, Issue 6
November and December 2020
Pages 748-756

Files

History

  • Receive Date: 11 September 2020
  • Accept Date: 28 September 2020
  • First Publish Date: 18 October 2020

Share

How to cite

Statistics